From October 1, 2023 to December 31, 2023, the company has repurchased 1,385,217 shares, representing 4.19% for $25 million. With this, the company has completed the repurchase of 3,088,069 shares, representing 9.09% for $75 million under the buyback announced on January 4, 2023.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
32.18 USD | -0.56% |
|
-0.06% | +4.55% |
07-01 | Collegium Pharmaceutical, Inc.(NasdaqGS:COLL) added to Russell 2000 Growth-Defensive Index | CI |
07-01 | Collegium Pharmaceutical, Inc.(NasdaqGS:COLL) added to Russell 2000 Defensive Index | CI |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+4.55% | 1.05B | |
+56.89% | 823B | |
+39.52% | 627B | |
-6.55% | 353B | |
+15.99% | 320B | |
+7.92% | 295B | |
+13.74% | 239B | |
+13.83% | 220B | |
-0.49% | 219B | |
+7.94% | 167B |
- Stock Market
- Equities
- COLL Stock
- News Collegium Pharmaceutical, Inc.
- Tranche Update on Collegium Pharmaceutical, Inc.'s Equity Buyback Plan announced on January 4, 2023.